Gene · 6007
Papers4,511
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,511
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of the clinical effect of a nationwide implementation of targeted routine antenatal anti-D prophylaxis in Denmark. | Transfusion | 2025 | 39692166 | PubTator, text mining | PubMed |
| The Use of Novel Therapies in the Management of Haemolytic Disease of the Fetus and Newborn (HDFN): Scientific Impact Paper No. 75. | BJOG | 2025 | 39689914 | PubTator, text mining | PubMed |
| Janus-like behavior of intrinsically disordered regions in reticulophagy. | Autophagy | 2025 | 39653037 | PubTator, text mining | PubMed |
Real-world performance of a clinical droplet digital polymerase chain reaction assay for non-invasive foetal blood group and platelet antigen genotyping of alloimmunized pregnant women with antibodies directed against RhD, RhE, Rhc, RhC, K1, HPA-1a or HPA-5b: A 1-year experience. | Vox Sang | 2025 | 39647598 | PubTator, text mining | PubMed |
Transfusing selected RhD negative patients with RhD positive packed red cell concentrates resulted in lower frequency of anti-D development and saved almost two thousand RhD negative concentrates during 5 years. | Transfus Med | 2025 | 39626958 | PubTator, text mining | PubMed |
| Contextualizing prophylactic red blood cell antigen matching in the lifelong care of sickle cell disease and thalassaemia patients. | Br J Haematol | 2025 | 39622634 | PubTator, text mining | PubMed |
| RhD-negative red blood cells can be saved during liver transplantation in RhD-negative patients due to low risk of alloimmunization against RhD. | Transfusion | 2025 | 39601116 | PubTator, text mining | PubMed |
| Clinical Validation of a Prenatal Cell-Free DNA Screening Test for Fetal RHD in a Large U.S. Cohort. | Obstet Gynecol | 2025 | 39591628 | PubTator, text mining | PubMed |
| An unusual case of reagent interference in transfusion medicine workup: Pan reactive indirect antiglobulin test caused by commercial saline solution. | Transfus Med | 2025 | 39548858 | PubTator, text mining | PubMed |
| Monitoring and management of hemolytic disease of the fetus and newborn based on an international expert Delphi consensus. | Am J Obstet Gynecol | 2025 | 39547350 | PubTator, text mining | PubMed |
| A splice site variant defining the novel RHD*01(487-3G) allele in trans to RHD*DAR1.2. | Transfusion | 2025 | 39529456 | PubTator, text mining | PubMed |
| scooby: Modeling multi-modal genomic profiles from DNA sequence at single-cell resolution. | bioRxiv | 2025 | 39345504 | PubTator, text mining | PubMed |
| RhD-positive red blood cell allocation practice to RhD-negative patients before and during the COVID-19 pandemic. | Am J Clin Pathol | 2025 | 39287493 | PubTator, text mining | PubMed |
| The use of free DNA for fetal RHD genotyping in the Rh negative pregnant patient-the time has come. | Am J Obstet Gynecol | 2025 | 39153534 | PubTator, text mining | PubMed |
| Rh disease in Mexico: evaluating regional and institutional differences in treatment availability and disease management. | Blood Transfus | 2025 | 39133627 | PubTator, text mining | PubMed |
| Red blood cell alloimmunization in transfused patients with myelodysplastic syndromes: a retrospective study from northern China. | Lab Med | 2025 | 39066582 | PubTator, text mining | PubMed |
| Noninvasive fetal blood group antigen genotyping. | Blood Transfus | 2025 | 38315532 | PubTator, text mining | PubMed |
| Serial intrauterine transfusion for severe fetal anemia due to anti-M alloimmunization. | Asian J Transfus Sci | 2024 | 39822700 | PubTator, text mining | PubMed |
| Serological comparison of weak D versus weakly reacting D by four different methods. | Asian J Transfus Sci | 2024 | 39822682 | PubTator, text mining | PubMed |
| Prevalence of ABO, Rh (D, C, c, E, and e), and Kell (K) antigens in blood donors: A single-center study from South India. | Asian J Transfus Sci | 2024 | 39822676 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6007/papers?page=12